A Function for Phosphatidylinositol 3-Kinase β (p85α-p110β) in Fibroblasts during Mitogenesis: Requirement for Insulin- and Lysophosphatidic Acid-Mediated Signal Transduction

作者: Serge Roche , J. Downward , Patrick Raynal , Sara A. Courtneidge

DOI: 10.1128/MCB.18.12.7119

关键词:

摘要: We have previously shown that phosphatidylinositol 3-kinase a (PI 3-Ka) (p85a-p110a) is required for DNA synthesis induced by various growth factors (S. Roche, M. Koegl, and S. A. Courtneidge, Proc. Natl. Acad. Sci. USA 91:9185‐9189, 1994) in fibroblasts. In the present study, we investigated function of PI 3-Kb (p85a-p110b) during mitogenesis. By using antibodies specific to p110b showed expressed NIH 3T3 cells. 3-Ka common features: tightly associated with protein serine kinase phosphorylates p85a, it interacts Src-middle T antigen complex activated platelet-derived factor (PDGF) receptor fibroblasts vivo, becomes tyrosine phosphorylated after PDGF stimulation. was also Swiss Cos7 cells stimulated lysophosphatidic acid (LPA), mitogen heterotrimeric G protein-coupled receptor. contrast lesser extent these Microinjection neutralizing into quiescent inhibited both insulin LPA but poorly affected signaling. Therefore, plays an important role transmitting mitogenic response some, not all, factors. Finally, show while oncogenic V12Ras type I 3-Ks, could induce absence active 3-Kb, suggesting Ras uses other effectors synthesis. Phosphatidylinositol 3-kinases 3-Ks) belong family enzymes phosphorylate phoshoinositides at 39 position inositol ring, leading formation phos

参考文章(52)
R. Dhand, I. Hiles, G. Panayotou, S. Roche, M.J. Fry, I. Gout, N.F. Totty, O. Truong, P. Vicendo, K. Yonezawa, PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. The EMBO Journal. ,vol. 13, pp. 522- 533 ,(1994) , 10.1002/J.1460-2075.1994.TB06290.X
G I Welsh, E J Foulstone, S W Young, J M Tavaré, C G Proud, Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochemical Journal. ,vol. 303, pp. 15- 20 ,(1994) , 10.1042/BJ3030015
E T Ulug, A J Cartwright, S A Courtneidge, Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase. Journal of Virology. ,vol. 66, pp. 1458- 1467 ,(1992) , 10.1128/JVI.66.3.1458-1467.1992
C.J. Vlahos, W.F. Matter, K.Y. Hui, R.F. Brown, A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry. ,vol. 269, pp. 5241- 5248 ,(1994) , 10.1016/S0021-9258(17)37680-9
Alex Toker, Lewis C. Cantley, Signalling through the lipid products of phosphoinositide-3-OH kinase Nature. ,vol. 387, pp. 673- 676 ,(1997) , 10.1038/42648
Pablo Rodriguez-Viciana, Patricia H. Warne, Ritu Dhand, Bart Vanhaesebroeck, Ivan Gout, Michael J. Fry, Michael D. Waterfield, Julian Downward, PHOSPHATIDYLINOSITOL-3-OH KINASE AS A DIRECT TARGET OF RAS Nature. ,vol. 370, pp. 527- 532 ,(1994) , 10.1038/370527A0
K. Yamauchi, K. Holt, J.E. Pessin, Phosphatidylinositol 3-kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription. Journal of Biological Chemistry. ,vol. 268, pp. 14597- 14600 ,(1993) , 10.1016/S0021-9258(18)82374-2
P Hu, A Mondino, E Y Skolnik, J Schlessinger, Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85 Molecular and Cellular Biology. ,vol. 13, pp. 7677- 7688 ,(1993) , 10.1128/MCB.13.12.7677
P. Rodriguez-Viciana, P. H. Warne, B. Vanhaesebroeck, M. D. Waterfield, J. Downward, Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. The EMBO Journal. ,vol. 15, pp. 2442- 2451 ,(1996) , 10.1002/J.1460-2075.1996.TB00602.X